MCP-1/CCL2 has been implicated in the pathogenesis of diseases characterized by monocytic infiltrates, like psoriasis, rheumatoid arthritis and atherosclerosis. MCP-1 is a biomarker for cardiovascular disease.
Features
Please refer to MCP-1 (Human) Recombinant #00220-01-100 for more information.